Insider Transactions in Q4 2022 at Walgreens Boots Alliance, Inc. (WBA)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2022
|
Kevin M. Ban EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,303
-26.96%
|
$412,120
$40.19 P/Share
|
|
Nov 18
2022
|
Kevin M. Ban EVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,303
+21.23%
|
$350,302
$34.04 P/Share
|
|
Nov 17
2022
|
Nancy M Schlichting Director |
SELL
Open market or private sale
|
Direct |
16,570
-75.03%
|
$646,230
$39.89 P/Share
|
|
Nov 01
2022
|
James Kehoe EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,678
-1.5%
|
$420,408
$36.26 P/Share
|
|
Nov 01
2022
|
James Kehoe EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
60,818
+18.79%
|
-
|
|
Nov 01
2022
|
Rosalind G Brewer CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,326
-2.41%
|
$335,736
$36.26 P/Share
|
|
Nov 01
2022
|
Rosalind G Brewer CEO |
BUY
Grant, award, or other acquisition
|
Direct |
155,280
+28.67%
|
-
|
|
Nov 01
2022
|
Manmohan Mahajan EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
815
-1.25%
|
$29,340
$36.26 P/Share
|
|
Nov 01
2022
|
Manmohan Mahajan EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
9,705
+30.56%
|
-
|
|
Nov 01
2022
|
Danielle Gray EVP and Global CLO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,229
-2.66%
|
$44,244
$36.26 P/Share
|
|
Nov 01
2022
|
Danielle Gray EVP and Global CLO |
BUY
Grant, award, or other acquisition
|
Direct |
33,644
+42.15%
|
-
|
|
Nov 01
2022
|
Holly May EVP, Global Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
957
-2.42%
|
$34,452
$36.26 P/Share
|
|
Nov 01
2022
|
Holly May EVP, Global Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,762
+42.93%
|
-
|
|
Nov 01
2022
|
Steven J Shulman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,136
+14.13%
|
-
|
|
Nov 01
2022
|
Kevin M. Ban EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
649
-1.15%
|
$23,364
$36.26 P/Share
|
|
Nov 01
2022
|
Kevin M. Ban EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,292
+45.19%
|
-
|
|
Nov 01
2022
|
John Patrick Driscoll EVP, Pres. U.S. Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
51,760
+50.0%
|
-
|
|
Nov 01
2022
|
Tracey D Brown EVP, Pres., Walgreens Retail |
SELL
Payment of exercise price or tax liability
|
Direct |
956
-2.52%
|
$34,416
$36.26 P/Share
|
|
Nov 01
2022
|
Tracey D Brown EVP, Pres., Walgreens Retail |
BUY
Grant, award, or other acquisition
|
Direct |
28,468
+42.83%
|
-
|
|
Nov 01
2022
|
Henry Lee Cooper EVP, Pres. Walgreens Pharmacy |
BUY
Grant, award, or other acquisition
|
Direct |
32,544
+49.99%
|
-
|
|
Nov 01
2022
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,515
+19.98%
|
-
|
|
Nov 01
2022
|
Ornella Barra Chief Operating Officer, Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
3,285
-1.01%
|
$118,260
$36.26 P/Share
|
|
Nov 01
2022
|
Ornella Barra Chief Operating Officer, Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
58,230
+15.23%
|
-
|
|
Nov 01
2022
|
Stefano Pessina Executive Chairman of Board |
SELL
Payment of exercise price or tax liability
|
Direct |
4,509
-0.54%
|
$162,324
$36.26 P/Share
|
|
Oct 26
2022
|
Manmohan Mahajan EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,311
-9.6%
|
$45,885
$35.51 P/Share
|
|
Oct 26
2022
|
Manmohan Mahajan EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
4,472
+24.67%
|
-
|
|
Oct 26
2022
|
James Kehoe EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
24,752
-10.91%
|
$866,320
$35.51 P/Share
|
|
Oct 26
2022
|
James Kehoe EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
57,498
+20.22%
|
-
|
|
Oct 26
2022
|
Ornella Barra Chief Operating Officer, Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
8,390
-3.06%
|
$293,650
$35.51 P/Share
|
|
Oct 26
2022
|
Ornella Barra Chief Operating Officer, Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
57,498
+17.33%
|
-
|
|
Oct 26
2022
|
Stefano Pessina Executive Chairman of Board |
BUY
Grant, award, or other acquisition
|
Direct |
371,281
+19.67%
|
-
|
|
Oct 26
2022
|
Stefano Pessina Executive Chairman of Board |
SELL
Sale (or disposition) back to the issuer
|
Direct |
33,547
-4.8%
|
$1,174,145
$35.51 P/Share
|